Ozempic: Weight Loss Drugs Led to Decline in U.S. Obesity Rate
A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of people utilizing GLP-1 weight loss drugs like Ozempic and Wegovy has risen sharply.
The poll found that women have a higher obesity rate than men and utilize weight management medications more often. People between the ages of 40 and 64 have higher obesity rates than other age groups and also use GLP-1 drugs more often.
However, the poll also reported that the rate of diabetes in the United States has climbed to a record high.
Author's summary: Obesity rate in US declines due to weight loss drugs.
More News
- Anker SOLIX Reshapes Australia's Home Energy Market with Proven Global Power | AAP
- The End of Eurobike? Who Will Lead the Bike Industry Now?
- Democrats' Tactics Undermine Earle-Sears in Virginia Race
- OpenAI unveils Aardvark, an autonomous GPT-5 agent built to hunt software vulnerabilities - SiliconANGLE
- Fresh Del Monte CEO sounds alarm as deadly fusarium wilt hits Ecuador’s banana crop: ‘It’s a losing battle’
- Quantum Threats Demand Post-Quantum Cryptography Now
- Editorial: Movable bike barrier a good step for Richmond Bridge
- ANZ flags $1.1b hit; Atlassian CFO exits; From prince to pauper
- The Best Breakup Songs, Definitively Ranked
- Why Australia’s big investors are so bloody angry